热带病与寄生虫学
熱帶病與寄生蟲學
열대병여기생충학
TROPICAL DISEASES AND PARASITOLOGY
2014年
2期
83-84,119
,共3页
王友斌%徐肇纲%贺正文%曹淳力
王友斌%徐肇綱%賀正文%曹淳力
왕우빈%서조강%하정문%조순력
晚期血吸虫病%腹水%治疗%效果
晚期血吸蟲病%腹水%治療%效果
만기혈흡충병%복수%치료%효과
Advanced schistosomiasis%Ascites%Treatment%Effect
目的：探索使用中药治疗腹水型晚期血吸虫病的效果。方法将312名腹水型晚期血吸虫病患者随机分成观察组和对照组,每组各156例。观察组的治疗药物为淋滞疏通方，对照组使用安体舒通和速尿注射液。治疗结束后观察腹水消退和复发情况。结果312例患者中，男性患者236例，女性患者76例；年龄8~79岁，平均年龄55.28岁。治疗后，观察组临床治疗总有效率为93.59%（146/156），对照组为74.36%（116/156），两组差异具有统计学意义（χ2=21.435，P<0.05）。观察组腹水消退时间少于对照组患者。观察组患者腹水复发率为27.52%（30/109），对照组为66.29%（59/89），两组差异具有统计学意义（χ2=29.760，P<0.05）。观察组患者副反应发生率为7.05%（11/156），对照组患者副反应发生率为94.86%（148/156），两组的差异具有统计学意义（χ2=240.717，P<0.05）。结论淋滞疏通方可作为腹水治疗药物在临床应用。
目的：探索使用中藥治療腹水型晚期血吸蟲病的效果。方法將312名腹水型晚期血吸蟲病患者隨機分成觀察組和對照組,每組各156例。觀察組的治療藥物為淋滯疏通方，對照組使用安體舒通和速尿註射液。治療結束後觀察腹水消退和複髮情況。結果312例患者中，男性患者236例，女性患者76例；年齡8~79歲，平均年齡55.28歲。治療後，觀察組臨床治療總有效率為93.59%（146/156），對照組為74.36%（116/156），兩組差異具有統計學意義（χ2=21.435，P<0.05）。觀察組腹水消退時間少于對照組患者。觀察組患者腹水複髮率為27.52%（30/109），對照組為66.29%（59/89），兩組差異具有統計學意義（χ2=29.760，P<0.05）。觀察組患者副反應髮生率為7.05%（11/156），對照組患者副反應髮生率為94.86%（148/156），兩組的差異具有統計學意義（χ2=240.717，P<0.05）。結論淋滯疏通方可作為腹水治療藥物在臨床應用。
목적：탐색사용중약치료복수형만기혈흡충병적효과。방법장312명복수형만기혈흡충병환자수궤분성관찰조화대조조,매조각156례。관찰조적치료약물위림체소통방，대조조사용안체서통화속뇨주사액。치료결속후관찰복수소퇴화복발정황。결과312례환자중，남성환자236례，녀성환자76례；년령8~79세，평균년령55.28세。치료후，관찰조림상치료총유효솔위93.59%（146/156），대조조위74.36%（116/156），량조차이구유통계학의의（χ2=21.435，P<0.05）。관찰조복수소퇴시간소우대조조환자。관찰조환자복수복발솔위27.52%（30/109），대조조위66.29%（59/89），량조차이구유통계학의의（χ2=29.760，P<0.05）。관찰조환자부반응발생솔위7.05%（11/156），대조조환자부반응발생솔위94.86%（148/156），량조적차이구유통계학의의（χ2=240.717，P<0.05）。결론림체소통방가작위복수치료약물재림상응용。
Objective To evaluate the effect of Linzhishutong on the patients with advanced schistosomi-asis ascites. Methods 312 advanced schistosomiasis ascites patients were randomly divided into trial group and control group, and each group with 156 cases. The patients in trial group were treated with chinese medicine Linzhishutong, and the patients in control group were treated with Antisterone and Furosemide injection. Af-ter treatment, the situations of ascites degrade and relapses were observed. Results Fou the 312 cases, the male was 236 and female was 76, the age range was from 8 to 79 years old, and the average age was 55.28. After treatment, the rate of general effective in trial group and control group was 93.59%(146/156)and 74.36%(116/156), respectively. There was significant differences(χ2=21.435, P<0.05)between the two groups. The ascites degrade time in the trial group was less than that in the control group. The ascites relapse rate in the trial group was 27.52%(30/109),and 66.29%(59/89) in the control group, and also there was significant differences(χ2=29.760, P<0.05)between the two groups. The side-effect rate in the trial group and control group was 7.05%(11/156) and 94.86%(148/156), respectively, with significant differences(χ2=240.717, P<0.05)between the two groups. Conclusions Linzhishutong is an optional chinese medicine for the clinical treatment to advanced schistosomiasis ascites.
